CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race for a better, Time-Limited leukemia treatment
Disease control OngoingThis study is testing which of two drug combinations works better for people newly diagnosed with a type of slow-growing blood cancer (CLL/SLL). About 600 participants will receive either acalabrutinib with venetoclax or venetoclax with obinutuzumab. The goal is to see if a treat…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New strategy aims to tame cancer before risky treatment
Disease control OngoingThis study is testing a new order for giving approved cancer drugs. The goal is to see if giving two drugs first can safely shrink the amount of cancer in the body. This could make it safer to start a third, powerful drug by lowering the risk of a dangerous side effect called tum…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC